News More data supports Jardiance lead in cardiovascular battle Cardioprotective effect occurred in patients independently of blood sugar control
News Boehringer to develop fibrosis treatment with Inventiva Boehringer to progress R&D partnership that began last year
News Galapagos and FibroGen drugs offer hope in IPF Drugs improve on existing medicines from Boehringer and Roche.
News Daiichi Sankyo anticoagulant gains EU label boost Label gives guidance in use when restoring normal heart rhythm
News Boehringer looks to cancer immunotherapy combinations BI developing combinations with its own checkpoint inhibitors
News Boosted by new drugs, Boehringer shrugs off patent expiry BI boosted by new diabetes and respiratory drugs.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
